Ha habido 50 transacciones internas recientes registradas para TScan Therapeutics, Inc. (TCRX), incluyendo 44 compras y 1 venta. El total de compras internas fue valorado en $23.55M y el total de ventas internas en $952.12K.
Internos destacados con actividad reciente incluyen Amello Jason, Macbeath Gavin, Zdraveski Zoran. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — TCRX
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-01-20 |
Amello Jason |
Chief Financial Officer |
Concesión de RSU |
350,000 |
$1.12 |
$392K |
350,000 |
| 2026-01-20 |
Macbeath Gavin |
Chief Executive Officer |
Concesión de RSU |
1,165,000 |
$1.12 |
$1.3M |
1,165,000 |
| 2026-01-20 |
Zdraveski Zoran |
See Remarks |
Concesión de RSU |
350,000 |
$1.12 |
$392K |
350,000 |
| 2026-01-20 |
Dworak Leiden |
See Remarks |
Concesión de RSU |
100,000 |
$1.12 |
$112K |
100,000 |
| 2026-01-20 |
Louis Chrystal |
Chief Medical Officer |
Concesión de RSU |
420,000 |
$1.12 |
$470.4K |
420,000 |
| 2025-12-23 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Compra Informativa |
6,232 |
$0.90 |
$5.6K |
8,019,148 |
| 2025-12-22 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Compra Informativa |
75,500 |
$0.90 |
$67.95K |
8,012,916 |
| 2025-12-19 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Compra Informativa |
80,069 |
$0.90 |
$71.97K |
7,937,416 |
| 2025-08-14 |
Dworak Leiden |
Principal Accounting Officer |
Desconocido |
37,500 |
$2.90 |
$108.75K |
- |
| 2025-06-30 |
Baker Bros. Advisors Lp |
Director |
Concesión de RSU |
67,000 |
$1.45 |
$97.15K |
67,000 |
| 2025-06-30 |
Dorton Katina |
Director |
Concesión de RSU |
67,000 |
$1.45 |
$97.15K |
67,000 |
| 2025-06-30 |
Nicholson Garry A |
Director |
Concesión de RSU |
67,000 |
$1.45 |
$97.15K |
67,000 |
| 2025-06-30 |
Klencke Barbara |
Director |
Concesión de RSU |
67,000 |
$1.45 |
$97.15K |
67,000 |
| 2025-06-30 |
Gruia Gabriela |
Director |
Concesión de RSU |
67,000 |
$1.45 |
$97.15K |
67,000 |
| 2025-06-30 |
Woods Keith |
Director |
Concesión de RSU |
67,000 |
$1.45 |
$97.15K |
67,000 |
| 2025-05-20 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Compra Informativa |
1,200,000 |
$1.20 |
$1.44M |
7,946,141 |
| 2025-05-19 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Compra Informativa |
1,388,794 |
$1.20 |
$1.67M |
6,746,141 |
| 2025-01-03 |
Amello Jason |
Chief Financial Officer |
Concesión de RSU |
270,000 |
$3.07 |
$827.55K |
270,000 |
| 2025-01-03 |
Macbeath Gavin |
Chief Executive Officer |
Concesión de RSU |
800,000 |
$3.07 |
$2.45M |
800,000 |
| 2025-01-03 |
Zdraveski Zoran |
See Remarks |
Concesión de RSU |
250,000 |
$3.07 |
$766.25K |
250,000 |
| 2025-01-03 |
Louis Chrystal |
Chief Medical Officer |
Concesión de RSU |
400,000 |
$3.07 |
$1.23M |
400,000 |
| 2024-12-26 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Compra Informativa |
7,500,000 |
$0.00 |
$750.00 |
7,500,000 |
| 2024-12-13 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Compra Informativa |
100,000 |
$2.90 |
$290.14K |
5,357,347 |
| 2024-12-12 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Compra Informativa |
31,800 |
$3.01 |
$95.63K |
5,257,347 |
| 2024-11-15 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Compra Informativa |
947 |
$4.34 |
$4.11K |
5,225,547 |
| 2024-09-23 |
Klencke Barbara |
Director |
Compra Informativa |
5,000 |
$5.29 |
$26.45K |
45,000 |
| 2024-08-26 |
Klencke Barbara |
Director |
Compra Informativa |
5,000 |
$5.53 |
$27.65K |
40,000 |
| 2024-08-23 |
Klencke Barbara |
Director |
Compra Informativa |
5,000 |
$5.69 |
$28.45K |
35,000 |
| 2024-08-23 |
Zdraveski Zoran |
See Remarks |
Venta Informativa |
164,686 |
$5.78 |
$952.12K |
4,716 |
| 2024-06-12 |
Baker Bros. Advisors Lp |
Director |
Concesión de RSU |
47,500 |
$8.88 |
$421.8K |
47,500 |
| 2024-06-12 |
Dorton Katina |
Director |
Concesión de RSU |
47,500 |
$8.88 |
$421.8K |
47,500 |
| 2024-06-12 |
Nicholson Garry A |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-06-12 |
Nicholson Garry A |
Director |
Concesión de RSU |
23,750 |
$8.88 |
$210.9K |
23,750 |
| 2024-06-12 |
Klencke Barbara |
Director |
Concesión de RSU |
47,500 |
$8.88 |
$421.8K |
47,500 |
| 2024-06-12 |
Gruia Gabriela |
Director |
Concesión de RSU |
47,500 |
$8.88 |
$421.8K |
47,500 |
| 2024-06-12 |
Woods Keith |
Director |
Concesión de RSU |
47,500 |
$8.88 |
$421.8K |
47,500 |
| 2024-05-01 |
Louis Chrystal |
Chief Medical Officer |
Concesión de RSU |
380,000 |
$8.62 |
$3.28M |
380,000 |
| 2024-04-22 |
Louis Chrystal |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-04-19 |
Baker Bros. Advisors Lp |
Director |
Compra Informativa |
825,968 |
$0.00 |
$82.60 |
4,018,678 |
| 2024-04-19 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Compra Informativa |
5,000,000 |
$0.00 |
$500.00 |
5,000,000 |
| 2024-02-01 |
Amello Jason |
Chief Financial Officer |
Concesión de RSU |
750,000 |
$5.15 |
$3.86M |
750,000 |
| 2024-01-29 |
Amello Jason |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-01-12 |
Macbeath Gavin |
Chief Executive Officer |
Concesión de RSU |
160,000 |
$6.00 |
$960K |
160,000 |
| 2024-01-12 |
Zdraveski Zoran |
See Remarks |
Concesión de RSU |
52,500 |
$6.00 |
$315K |
52,500 |
| 2024-01-12 |
Dworak Leiden |
Other: Vice President, Finance |
Concesión de RSU |
46,875 |
$6.00 |
$281.25K |
46,875 |
| 2023-12-19 |
Barberich Timothy J |
Director |
Compra Informativa |
317 |
$4.97 |
$1.58K |
67,027 |
| 2023-12-18 |
Barberich Timothy J |
Director |
Compra Informativa |
28,830 |
$4.89 |
$140.88K |
66,710 |
| 2023-12-14 |
Klencke Barbara |
Director |
Compra Informativa |
5,000 |
$5.08 |
$25.4K |
30,000 |
| 2023-12-06 |
Woods Keith |
Officer |
Desconocido |
- |
- |
- |
- |
| 2023-12-06 |
Woods Keith |
Director |
Concesión de RSU |
17,500 |
$6.74 |
$117.95K |
17,500 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
